data_1j4v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j4v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.489 0.185 . . . . 0.029999999999999999 110.74 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.32 -127.55 23.95 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 117.355 1.702 . . . . 0.02 117.355 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 68.89 22.54 7.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 115.942 1.83 . . . . 0.029999999999999999 115.942 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -54.87 -37.22 65.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.126 1.158 . . . . 0.02 114.126 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -55.37 -27.8 49.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.584 1.698 . . . . 0.02 115.584 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -65.97 -25.3 67.04 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.332 1.605 . . . . 0.02 115.332 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.3 p -126.77 25.62 6.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.545 1.313 . . . . 0.029999999999999999 114.545 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.2 m -134.6 166.85 21.95 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.186 -1.042 . . . . 0.02 108.186 178.849 -53.823 -107.445 98.738 104.696 2.031 103.0 -84.448 -56.619 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -153.02 169.3 23.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.153 -0.684 . . . . 0.029999999999999999 109.153 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 59.58 38.28 22.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.02 111.129 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.1 m -76.47 149.05 36.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.02 109.773 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.87 152.9 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.02 111.063 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.9 mt -122.96 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -133.72 113.47 12.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 103.384 -2.821 . . . . 0.02 103.384 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.24 -118.97 12.94 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 107.89 -2.084 . . . . 0.02 107.89 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -106.67 3.0 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.572 -0.369 . . . . 0.02 111.42 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.64 127.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 116.564 2.061 . . . . 0.02 116.564 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.5 tp -100.57 130.84 46.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m -125.75 140.43 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.474 -1.676 . . . . 0.02 106.474 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -157.25 157.44 34.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.405 -0.518 . . . . 0.02 111.052 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -106.73 116.15 31.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 105.343 -2.095 . . . . 0.02 105.343 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.69 151.44 37.97 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 117.399 2.37 . . . . 0.029999999999999999 117.399 -175.352 -56.619 -84.448 98.738 103.0 2.031 104.696 -107.445 -53.823 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.8 136.55 45.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.149 -0.932 . . . . 0.029999999999999999 112.514 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.28 162.4 14.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.56 -1.645 . . . . 0.029999999999999999 106.56 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.5 m -59.95 -52.44 65.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.029999999999999999 111.848 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -72.95 10.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.664 0.616 . . . . 0.040000000000000001 112.664 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.94 168.74 40.82 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.552 -1.819 . . . . 0.029999999999999999 108.552 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.22 176.12 49.81 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.055 -1.618 . . . . 0.029999999999999999 109.055 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -133.68 166.46 22.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.952 1.093 . . . . 0.029999999999999999 113.952 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -146.51 138.68 24.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.571 -1.27 . . . . 0.029999999999999999 107.571 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.9 m -102.99 133.8 47.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.581 -1.637 . . . . 0.029999999999999999 106.581 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -146.54 168.01 22.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.02 110.372 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.9 m -132.13 159.72 38.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.611 -0.722 . . . . 0.02 110.639 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.65 129.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.206 -1.035 . . . . 0.02 108.206 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -86.89 112.96 22.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.187 -1.042 . . . . 0.02 108.187 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.2 mt -79.01 -6.37 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.377 1.621 . . . . 0.02 115.377 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -54.91 -34.42 63.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 114.24 1.2 . . . . 0.02 114.24 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.6 p -89.51 -2.63 58.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 115.609 1.707 . . . . 0.02 115.609 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 50' ' ' GLN . 24.5 m -122.62 -9.15 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 114.744 1.387 . . . . 0.02 114.744 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.1 mt -125.72 141.88 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.896 -0.779 . . . . 0.02 108.896 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' OE1' ' NE2' ' A' ' 50' ' ' GLN . 11.7 pt-20 -138.33 156.45 47.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.752 0.649 . . . . 0.029999999999999999 112.752 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -94.1 111.15 22.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.147 -0.933 . . . . 0.02 109.707 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.7 t -110.86 101.6 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.181 -1.044 . . . . 0.029999999999999999 108.181 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 35.4 t0 51.83 44.18 29.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.392 0.886 . . . . 0.029999999999999999 113.392 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.39 81.51 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 117.405 1.722 . . . . 0.02 117.405 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.4 t -118.01 130.55 56.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.881 0.341 . . . . 0.02 111.048 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -75.13 126.48 31.12 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.535 -0.913 . . . . 0.02 108.535 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -130.13 155.45 46.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 0.02 110.025 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -69.96 151.95 45.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.267 -1.383 . . . . 0.029999999999999999 107.267 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.555 ' CG ' ' CD ' ' A' ' 51' ' ' PRO . 49.9 tt0 -133.3 158.93 74.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.029999999999999999 111.057 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' CD ' ' CG ' ' A' ' 50' ' ' GLN . 30.1 Cg_endo -53.11 -177.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 N-CA-C 108.972 -1.203 . . . . 0.040000000000000001 108.972 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.6 p -78.96 -179.94 6.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.922 0.712 . . . . 0.029999999999999999 112.922 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 2.7 p-10 -73.09 -165.46 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.448 -0.501 . . . . 0.040000000000000001 111.509 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.18 -32.46 6.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.16 -1.052 . . . . 0.040000000000000001 108.16 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.7 pt -74.48 -10.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.541 0.571 . . . . 0.02 112.541 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -81.15 -27.85 35.31 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.015 -0.365 . . . . 0.029999999999999999 110.015 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -116.86 2.76 12.85 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 114.627 1.343 . . . . 0.02 114.627 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.6 m -127.14 151.81 48.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.779 -1.193 . . . . 0.02 107.779 178.299 -58.519 -104.154 101.525 105.113 2.038 104.25 -80.485 -64.993 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -136.8 170.89 15.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.174 0.511 . . . . 0.02 110.047 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.55 52.8 14.12 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.312 0.856 . . . . 0.02 113.312 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 p -73.32 138.31 45.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.177 -1.416 . . . . 0.01 107.177 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -148.39 154.96 40.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.01 110.634 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -93.49 113.84 26.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.082 -2.192 . . . . 0.02 105.082 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -98.77 119.75 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.018 -1.104 . . . . 0.01 108.018 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.24 -140.05 26.83 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.531 -1.428 . . . . 0.02 109.531 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -102.04 -11.96 18.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.105 1.52 . . . . 0.02 115.105 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.7 p -151.13 5.03 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 117.072 2.249 . . . . 0.02 117.072 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -93.03 127.71 38.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.129 1.159 . . . . 0.01 114.129 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 tp -95.65 119.96 35.07 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.159 -2.163 . . . . 0.02 105.159 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.75 39.48 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 0.01 109.342 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -168.3 170.5 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.159 0.504 . . . . 0.01 110.864 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.26 116.25 30.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 103.343 -2.836 . . . . 0.02 103.343 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -118.51 148.4 42.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.229 1.196 . . . . 0.02 114.229 -178.1 -64.993 -80.485 101.525 104.25 2.038 105.113 -104.154 -58.519 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.94 138.12 39.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.66 -0.7 . . . . 0.029999999999999999 112.558 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.1 p -89.43 178.52 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.979 -1.489 . . . . 0.029999999999999999 106.979 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -61.5 -29.19 69.83 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.002 . . . . 0.029999999999999999 108.293 178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.18 5.92 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.721 -0.672 . . . . 0.029999999999999999 112.463 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 68.7 26.63 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.327 1.602 . . . . 0.029999999999999999 115.327 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -114.85 143.64 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.702 -0.851 . . . . 0.029999999999999999 108.702 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.242 0.831 . . . . 0.02 113.242 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -132.02 158.88 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.686 -1.227 . . . . 0.02 107.686 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.6 t -81.91 137.18 35.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.02 111.108 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -149.57 159.98 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.02 110.62 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.41 160.4 41.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.381 -0.6 . . . . 0.02 109.381 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.88 138.81 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.779 -1.193 . . . . 0.02 107.779 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -83.03 109.27 16.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.815 0.341 . . . . 0.02 111.13 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.98 -20.54 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.522 0.564 . . . . 0.02 112.522 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.6 -12.35 57.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 119.811 -0.756 . . . . 0.02 110.896 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.04 -41.44 98.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.074 0.398 . . . . 0.02 112.074 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -134.81 -4.03 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 118.065 2.617 . . . . 0.02 118.065 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.25 118.19 46.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 119.754 -0.779 . . . . 0.02 109.056 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 160.62 19.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.447 0.906 . . . . 0.029999999999999999 113.447 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -100.41 102.65 13.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.473 -2.047 . . . . 0.029999999999999999 105.473 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.63 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.608 -1.256 . . . . 0.029999999999999999 107.608 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.0 t0 48.79 46.01 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.843 1.053 . . . . 0.029999999999999999 113.843 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.49 70.19 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 117.672 1.829 . . . . 0.029999999999999999 117.672 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.1 m -121.43 134.16 55.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.493 0.647 . . . . 0.029999999999999999 111.742 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.04 127.44 32.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.029999999999999999 110.039 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.87 142.5 33.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.029999999999999999 111.8 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -82.82 144.4 30.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.825 -0.805 . . . . 0.029999999999999999 108.825 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 108.764 -0.828 . . . . 0.029999999999999999 108.764 177.699 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.503 0.192 . . . . 0.029999999999999999 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 68.27 -127.53 24.06 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 117.346 1.698 . . . . 0.029999999999999999 117.346 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 68.87 22.55 7.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.951 1.834 . . . . 0.029999999999999999 115.951 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -54.9 -37.23 66.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.11 1.152 . . . . 0.02 114.11 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' SER . . . . . . . . . . . . . 60.3 p -55.33 -27.86 49.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.598 1.703 . . . . 0.02 115.598 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -65.95 -25.29 67.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.382 1.623 . . . . 0.029999999999999999 115.382 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 65.5 p -126.72 25.65 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.539 1.311 . . . . 0.029999999999999999 114.539 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' CYS . . . . . . . . . . . . . 56.2 m -134.6 166.82 22.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.238 -1.023 . . . . 0.02 108.238 178.86 -53.786 -107.447 98.735 104.694 2.03 103.005 -84.535 -56.534 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -153.06 169.28 23.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.141 -0.688 . . . . 0.029999999999999999 109.141 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 59.65 38.23 22.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.02 111.13 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -76.48 149.03 36.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.02 109.722 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -156.83 152.96 27.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.905 -0.589 . . . . 0.02 110.939 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 16.5 mm -120.43 129.79 75.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.206 -0.906 . . . . 0.02 108.686 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -135.13 113.51 11.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 103.374 -2.824 . . . . 0.02 103.374 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.25 -119.0 12.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.947 -2.061 . . . . 0.02 107.947 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' SER . . . . . . . . . . . . . 95.6 p -106.65 3.07 26.4 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.609 -0.348 . . . . 0.02 111.431 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.64 127.7 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 116.604 2.076 . . . . 0.02 116.604 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 19.4 tp -100.57 130.86 46.69 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.762 -1.57 . . . . 0.02 106.762 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 98.0 m -125.76 140.45 52.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.458 -1.682 . . . . 0.02 106.458 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 19.1 t -157.22 157.46 34.36 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.418 -0.513 . . . . 0.02 111.083 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' THR . . . . . . . . . . . . . 96.2 m -106.79 116.24 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 105.332 -2.099 . . . . 0.029999999999999999 105.332 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' CYS . . . . . . . . . . . . . 61.9 m -118.71 151.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 117.448 2.388 . . . . 0.029999999999999999 117.448 -175.358 -56.534 -84.535 98.735 103.005 2.03 104.694 -107.447 -53.786 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 136.54 45.48 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.225 -0.898 . . . . 0.029999999999999999 112.484 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.25 162.38 14.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.593 -1.632 . . . . 0.040000000000000001 106.593 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 85.2 m -59.88 -52.52 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.766 0.317 . . . . 0.040000000000000001 111.837 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -73.0 11.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.594 0.591 . . . . 0.040000000000000001 112.594 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 91.95 168.76 40.83 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -1.833 . . . . 0.040000000000000001 108.518 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.12 176.12 49.89 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 109.117 -1.593 . . . . 0.040000000000000001 109.117 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -133.64 166.46 22.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 114.016 1.117 . . . . 0.029999999999999999 114.016 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.537 -1.283 . . . . 0.029999999999999999 107.537 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' THR . . . . . . . . . . . . . 95.8 m -102.99 133.82 47.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.582 -1.636 . . . . 0.029999999999999999 106.582 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 95.7 p -146.52 168.04 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.029999999999999999 110.385 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 54.3 m -132.2 159.7 38.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.608 -0.724 . . . . 0.02 110.633 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ILE . . . . . . . . . . . . . 20.1 tt -147.64 129.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -86.91 112.92 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.199 -1.037 . . . . 0.02 108.199 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 37.8 mt -78.92 -6.44 56.19 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.411 1.634 . . . . 0.02 115.411 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -54.86 -34.44 62.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.215 1.191 . . . . 0.02 114.215 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 95.6 p -89.42 -2.73 58.5 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.662 1.727 . . . . 0.029999999999999999 115.662 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' B' ' 250' ' ' GLN . 24.3 m -122.65 -9.11 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 114.701 1.371 . . . . 0.02 114.701 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' ILE . . . . . . . . . . . . . 81.2 mt -125.78 141.88 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.899 -0.778 . . . . 0.02 108.899 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLU . . . . . 0.562 ' OE1' ' NE2' ' B' ' 250' ' ' GLN . 11.7 pt-20 -138.28 156.48 47.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.738 0.644 . . . . 0.029999999999999999 112.738 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -94.09 111.08 22.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.148 -0.933 . . . . 0.02 109.73 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.85 101.62 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.19 -1.041 . . . . 0.029999999999999999 108.19 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ASP . . . . . . . . . . . . . 35.4 t0 51.83 44.22 29.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.353 0.871 . . . . 0.029999999999999999 113.353 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.04 -2.34 81.53 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 117.399 1.719 . . . . 0.02 117.399 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 42.5 t -118.05 130.46 56.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.909 0.355 . . . . 0.02 111.045 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 95.2 mt -75.09 126.55 31.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.498 -0.927 . . . . 0.02 108.498 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -130.18 155.35 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.02 110.012 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -70.13 152.86 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.277 -1.379 . . . . 0.029999999999999999 107.277 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . 0.563 ' CG ' ' CD ' ' B' ' 251' ' ' PRO . 50.6 tt0 -134.48 159.02 73.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.631 -0.713 . . . . 0.029999999999999999 111.027 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' PRO . . . . . 0.563 ' CD ' ' CG ' ' B' ' 250' ' ' GLN . 29.8 Cg_endo -53.06 -177.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 N-CA-C 108.971 -1.204 . . . . 0.040000000000000001 108.971 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 82.9 p -78.73 -179.74 6.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.91 0.707 . . . . 0.029999999999999999 112.91 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' B' ' 253' ' ' ASN . 2.9 p-10 -74.61 -165.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.466 -0.494 . . . . 0.040000000000000001 111.52 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.51 -33.58 5.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.159 -1.052 . . . . 0.050000000000000003 108.159 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' ILE . . . . . . . . . . . . . 44.7 pt -71.82 -10.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 120.703 -1.248 . . . . 0.02 112.527 177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -81.19 -27.86 35.17 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.981 -0.377 . . . . 0.029999999999999999 109.981 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -116.83 2.81 12.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.659 1.355 . . . . 0.02 114.659 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m -127.18 151.78 48.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.725 -1.213 . . . . 0.02 107.725 178.341 -58.582 -104.102 101.475 105.146 2.038 104.306 -80.467 -65.01 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -136.81 170.86 15.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.49 . . . . 0.02 110.061 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.54 52.82 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.35 0.871 . . . . 0.02 113.35 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 58.6 p -73.34 138.39 45.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.159 -1.423 . . . . 0.02 107.159 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -148.48 154.9 40.47 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.913 -0.315 . . . . 0.01 110.604 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' LEU . . . . . . . . . . . . . 58.3 tp -93.43 113.8 26.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 105.115 -2.18 . . . . 0.02 105.115 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' ALA . . . . . . . . . . . . . . . -98.72 119.74 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.027 -1.101 . . . . 0.01 108.027 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.21 -140.04 26.84 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.581 -1.408 . . . . 0.02 109.581 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' SER . . . . . . . . . . . . . 66.4 p -101.99 -12.09 18.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.108 1.521 . . . . 0.02 115.108 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 94.1 p -151.11 5.04 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 117.058 2.244 . . . . 0.02 117.058 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -93.06 127.7 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.098 1.148 . . . . 0.02 114.098 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 24.1 tp -95.65 119.95 35.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.193 -2.151 . . . . 0.02 105.193 176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -115.75 148.73 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.249 -0.649 . . . . 0.01 109.249 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -168.28 170.53 9.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.134 0.492 . . . . 0.02 110.854 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.27 116.24 30.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 103.302 -2.851 . . . . 0.02 103.302 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.59 148.31 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.237 1.199 . . . . 0.02 114.237 -178.128 -65.01 -80.467 101.475 104.306 2.038 105.146 -104.102 -58.582 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.82 138.08 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 0.029999999999999999 112.663 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' THR . . . . . . . . . . . . . 59.0 p -89.38 178.51 6.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.995 -1.483 . . . . 0.029999999999999999 106.995 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' ARG . . . . . . . . . . . . . 14.8 mmt85 -61.5 -29.22 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 0.029999999999999999 108.24 178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.17 5.91 13.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.807 -0.633 . . . . 0.029999999999999999 112.502 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 68.76 26.68 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.263 1.579 . . . . 0.029999999999999999 115.263 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.85 143.59 44.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.714 -0.847 . . . . 0.029999999999999999 108.714 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -84.7 133.66 34.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.258 0.836 . . . . 0.02 113.258 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' VAL . . . . . . . . . . . . . 32.0 m -132.06 158.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.633 -1.247 . . . . 0.02 107.633 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 67.5 m -81.01 138.45 36.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.34 -0.391 . . . . 0.02 111.074 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 9.7 t -150.66 160.02 44.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.274 -0.421 . . . . 0.02 110.639 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.38 160.44 41.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.423 -0.584 . . . . 0.02 109.423 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 20.0 tt -148.01 138.77 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.767 -1.197 . . . . 0.02 107.767 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -83.02 109.35 17.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.759 0.314 . . . . 0.02 111.071 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.99 -20.63 66.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.477 0.547 . . . . 0.02 112.477 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -66.56 -12.37 57.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.811 -0.756 . . . . 0.02 110.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.01 -41.43 98.06 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.123 0.416 . . . . 0.02 112.123 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -134.8 -4.04 2.53 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 118.098 2.629 . . . . 0.02 118.098 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.24 118.2 46.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 119.7 -0.8 . . . . 0.02 109.019 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' ALA . . . . . . . . . . . . . . . -115.1 160.59 19.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.436 0.902 . . . . 0.02 113.436 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -100.35 102.64 13.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.461 -2.051 . . . . 0.029999999999999999 105.461 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' ILE . . . . . . . . . . . . . 40.1 mm -100.61 98.31 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.637 -1.246 . . . . 0.029999999999999999 107.637 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' ASP . . . . . . . . . . . . . 31.9 t0 48.66 46.07 21.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.893 1.072 . . . . 0.029999999999999999 113.893 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' GLY . . . . . . . . . . . . . . . 94.12 -3.58 70.03 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 117.647 1.819 . . . . 0.029999999999999999 117.647 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 49.8 m -121.44 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.029999999999999999 111.701 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.0 127.43 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.02 110.037 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.86 142.61 33.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.941 0.401 . . . . 0.029999999999999999 111.782 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -82.92 144.36 30.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.738 -0.838 . . . . 0.029999999999999999 108.738 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 108.786 -0.82 . . . . 0.029999999999999999 108.786 177.649 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.489 0.185 . . . . 0.03 110.74 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.32 -127.55 23.95 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 117.355 1.702 . . . . 0.02 117.355 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 68.89 22.54 7.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 115.942 1.83 . . . . 0.03 115.942 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -54.87 -37.22 65.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.126 1.158 . . . . 0.02 114.126 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -55.37 -27.8 49.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.584 1.698 . . . . 0.02 115.584 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -65.97 -25.3 67.04 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.332 1.605 . . . . 0.02 115.332 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.3 p -126.77 25.62 6.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.545 1.313 . . . . 0.03 114.545 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.2 m -134.6 166.85 21.95 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.186 -1.042 . . . . 0.02 108.186 178.849 -53.823 -107.445 98.738 104.696 2.031 103.0 -84.448 -56.619 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -153.02 169.3 23.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.153 -0.684 . . . . 0.03 109.153 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 59.58 38.28 22.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.02 111.129 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.1 m -76.47 149.05 36.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.02 109.773 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.87 152.9 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.02 111.063 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.648 HD13 HD13 ' B' ' 269' ' ' LEU . 75.9 mt -122.96 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -133.72 113.47 12.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 103.384 -2.821 . . . . 0.02 103.384 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.24 -118.97 12.94 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 107.89 -2.084 . . . . 0.02 107.89 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' B' ' 255' ' ' ILE . 95.7 p -106.67 3.0 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.572 -0.369 . . . . 0.02 111.42 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.64 127.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 116.564 2.061 . . . . 0.02 116.564 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.5 tp -100.57 130.84 46.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m -125.75 140.43 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.474 -1.676 . . . . 0.02 106.474 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -157.25 157.44 34.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.405 -0.518 . . . . 0.02 111.052 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -106.73 116.15 31.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 105.343 -2.095 . . . . 0.02 105.343 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.69 151.44 37.97 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 117.399 2.37 . . . . 0.03 117.399 -175.352 -56.619 -84.448 98.738 103.0 2.031 104.696 -107.445 -53.823 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.8 136.55 45.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.149 -0.932 . . . . 0.03 112.514 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.28 162.4 14.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.56 -1.645 . . . . 0.03 106.56 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.5 m -59.95 -52.44 65.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.03 111.848 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -72.95 10.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.664 0.616 . . . . 0.04 112.664 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.94 168.74 40.82 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.552 -1.819 . . . . 0.03 108.552 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.22 176.12 49.81 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.055 -1.618 . . . . 0.03 109.055 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -133.68 166.46 22.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.952 1.093 . . . . 0.03 113.952 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -146.51 138.68 24.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.571 -1.27 . . . . 0.03 107.571 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.9 m -102.99 133.8 47.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.581 -1.637 . . . . 0.02 106.581 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -146.54 168.01 22.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.02 110.372 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.9 m -132.13 159.72 38.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.611 -0.722 . . . . 0.02 110.639 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.65 129.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.206 -1.035 . . . . 0.02 108.206 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -86.89 112.96 22.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.187 -1.042 . . . . 0.02 108.187 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.2 mt -79.01 -6.37 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.377 1.621 . . . . 0.02 115.377 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.521 HD21 ' CD1' ' B' ' 255' ' ' ILE . 4.8 m-20 -54.91 -34.42 63.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 114.24 1.2 . . . . 0.02 114.24 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.6 p -89.51 -2.63 58.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 115.609 1.707 . . . . 0.02 115.609 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 50' ' ' GLN . 24.5 m -122.62 -9.15 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 114.744 1.387 . . . . 0.02 114.744 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.1 mt -125.72 141.88 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.896 -0.779 . . . . 0.02 108.896 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' OE1' ' NE2' ' A' ' 50' ' ' GLN . 11.7 pt-20 -138.33 156.45 47.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.752 0.649 . . . . 0.03 112.752 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -94.1 111.15 22.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.147 -0.933 . . . . 0.02 109.707 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.7 t -110.86 101.6 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.181 -1.044 . . . . 0.03 108.181 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' B' ' 276' ' ' ARG . 35.4 t0 51.83 44.18 29.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.392 0.886 . . . . 0.03 113.392 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.39 81.51 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 117.405 1.722 . . . . 0.02 117.405 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.4 t -118.01 130.55 56.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.881 0.341 . . . . 0.02 111.048 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -75.13 126.48 31.12 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.535 -0.913 . . . . 0.02 108.535 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -130.13 155.45 46.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 0.02 110.025 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 57.6 m95 -69.96 151.95 45.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.267 -1.383 . . . . 0.03 107.267 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.936 ' CG ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tt0 -133.3 158.93 74.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.03 111.057 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD2' ' CG ' ' A' ' 50' ' ' GLN . 30.1 Cg_endo -53.11 -177.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 N-CA-C 108.972 -1.203 . . . . 0.04 108.972 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.6 p -78.96 -179.94 6.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.922 0.712 . . . . 0.03 112.922 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 2.7 p-10 -73.09 -165.46 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.448 -0.501 . . . . 0.04 111.509 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' HE2' ' CB ' ' B' ' 216' ' ' SER . 0.1 OUTLIER -113.18 -32.46 6.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.16 -1.052 . . . . 0.04 108.16 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' B' ' 216' ' ' SER . 44.7 pt -74.48 -10.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.541 0.571 . . . . 0.02 112.541 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' HB2' HD21 ' A' ' 53' ' ' ASN . 18.1 tp10 -81.15 -27.85 35.31 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.015 -0.365 . . . . 0.03 110.015 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -116.86 2.76 12.85 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 114.627 1.343 . . . . 0.02 114.627 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.6 m -127.14 151.81 48.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.779 -1.193 . . . . 0.02 107.779 178.299 -58.519 -104.154 101.525 105.113 2.038 104.25 -80.485 -64.993 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -136.8 170.89 15.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.174 0.511 . . . . 0.02 110.047 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.55 52.8 14.12 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.312 0.856 . . . . 0.01 113.312 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 p -73.32 138.31 45.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.177 -1.416 . . . . 0.01 107.177 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -148.39 154.96 40.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.01 110.634 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -93.49 113.84 26.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.082 -2.192 . . . . 0.02 105.082 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 68' ' ' GLU . . . -98.77 119.75 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.018 -1.104 . . . . 0.01 108.018 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.24 -140.05 26.83 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.531 -1.428 . . . . 0.02 109.531 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -102.04 -11.96 18.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.105 1.52 . . . . 0.02 115.105 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.7 p -151.13 5.03 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 117.072 2.249 . . . . 0.02 117.072 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 18.0 tp10 -93.03 127.71 38.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.129 1.159 . . . . 0.01 114.129 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 tp -95.65 119.96 35.07 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.159 -2.163 . . . . 0.02 105.159 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.75 39.48 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 0.01 109.342 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -168.3 170.5 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.159 0.504 . . . . 0.01 110.864 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.26 116.25 30.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 103.343 -2.836 . . . . 0.02 103.343 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -118.51 148.4 42.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.229 1.196 . . . . 0.02 114.229 -178.1 -64.993 -80.485 101.525 104.25 2.038 105.113 -104.154 -58.519 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 56.6 mtpt -76.94 138.12 39.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.66 -0.7 . . . . 0.03 112.558 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.1 p -89.43 178.52 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.979 -1.489 . . . . 0.03 106.979 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.643 ' HG3' HH11 ' A' ' 76' ' ' ARG . 14.8 mmt85 -61.5 -29.19 69.83 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.002 . . . . 0.03 108.293 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.18 5.92 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.721 -0.672 . . . . 0.03 112.463 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 68.7 26.63 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.327 1.602 . . . . 0.03 115.327 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -114.85 143.64 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.702 -0.851 . . . . 0.03 108.702 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 51.9 m-85 -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.242 0.831 . . . . 0.02 113.242 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -132.02 158.88 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.686 -1.227 . . . . 0.02 107.686 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.6 t -81.91 137.18 35.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.02 111.108 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -149.57 159.98 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.02 110.62 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.41 160.4 41.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.381 -0.6 . . . . 0.02 109.381 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.88 138.81 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.779 -1.193 . . . . 0.02 107.779 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -83.03 109.27 16.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.815 0.341 . . . . 0.02 111.13 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.98 -20.54 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.522 0.564 . . . . 0.02 112.522 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.6 -12.35 57.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 119.811 -0.756 . . . . 0.02 110.896 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.04 -41.44 98.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.074 0.398 . . . . 0.02 112.074 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -134.81 -4.03 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 118.065 2.617 . . . . 0.02 118.065 -176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.25 118.19 46.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 119.754 -0.779 . . . . 0.02 109.056 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 160.62 19.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.447 0.906 . . . . 0.03 113.447 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -100.41 102.65 13.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.473 -2.047 . . . . 0.03 105.473 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.63 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.608 -1.256 . . . . 0.03 107.608 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.0 t0 48.79 46.01 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.843 1.053 . . . . 0.03 113.843 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.49 70.19 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 117.672 1.829 . . . . 0.03 117.672 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.1 m -121.43 134.16 55.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.493 0.647 . . . . 0.03 111.742 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.04 127.44 32.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.03 110.039 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.87 142.5 33.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.03 111.8 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -82.82 144.4 30.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.825 -0.805 . . . . 0.03 108.825 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 108.764 -0.828 . . . . 0.03 108.764 177.699 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.503 0.192 . . . . 0.03 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 68.27 -127.53 24.06 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 117.346 1.698 . . . . 0.02 117.346 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 68.87 22.55 7.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.951 1.834 . . . . 0.03 115.951 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -54.9 -37.23 66.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.11 1.152 . . . . 0.02 114.11 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' SER . . . . . . . . . . . . . 60.3 p -55.33 -27.86 49.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.598 1.703 . . . . 0.02 115.598 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -65.95 -25.29 67.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.382 1.623 . . . . 0.03 115.382 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 65.5 p -126.72 25.65 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.539 1.311 . . . . 0.03 114.539 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' CYS . . . . . . . . . . . . . 56.2 m -134.6 166.82 22.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.238 -1.023 . . . . 0.02 108.238 178.86 -53.786 -107.447 98.735 104.694 2.03 103.005 -84.535 -56.534 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -153.06 169.28 23.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.141 -0.688 . . . . 0.03 109.141 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 59.65 38.23 22.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.02 111.13 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -76.48 149.03 36.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.02 109.722 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -156.83 152.96 27.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.905 -0.589 . . . . 0.02 110.939 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' B' ' 218' ' ' LEU . 16.5 mm -120.43 129.79 75.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.206 -0.906 . . . . 0.02 108.686 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -135.13 113.51 11.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 103.374 -2.824 . . . . 0.02 103.374 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.25 -119.0 12.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.947 -2.061 . . . . 0.02 107.947 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' SER . . . . . 0.51 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 95.6 p -106.65 3.07 26.4 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.609 -0.348 . . . . 0.02 111.431 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.64 127.7 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 116.604 2.076 . . . . 0.02 116.604 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.52 ' HA ' HD13 ' B' ' 213' ' ' ILE . 19.4 tp -100.57 130.86 46.69 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.762 -1.57 . . . . 0.02 106.762 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 98.0 m -125.76 140.45 52.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.458 -1.682 . . . . 0.02 106.458 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 19.1 t -157.22 157.46 34.36 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.418 -0.513 . . . . 0.02 111.083 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' THR . . . . . . . . . . . . . 96.2 m -106.79 116.24 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 105.332 -2.099 . . . . 0.03 105.332 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' CYS . . . . . . . . . . . . . 61.9 m -118.71 151.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 117.448 2.388 . . . . 0.03 117.448 -175.358 -56.534 -84.535 98.735 103.005 2.03 104.694 -107.447 -53.786 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 136.54 45.48 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.225 -0.898 . . . . 0.03 112.484 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.25 162.38 14.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.593 -1.632 . . . . 0.04 106.593 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 85.2 m -59.88 -52.52 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.766 0.317 . . . . 0.04 111.837 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -73.0 11.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.594 0.591 . . . . 0.04 112.594 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 91.95 168.76 40.83 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -1.833 . . . . 0.04 108.518 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.12 176.12 49.89 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 109.117 -1.593 . . . . 0.04 109.117 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -133.64 166.46 22.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 114.016 1.117 . . . . 0.03 114.016 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.537 -1.283 . . . . 0.03 107.537 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' THR . . . . . . . . . . . . . 95.8 m -102.99 133.82 47.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.582 -1.636 . . . . 0.03 106.582 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 95.7 p -146.52 168.04 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.03 110.385 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 54.3 m -132.2 159.7 38.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.608 -0.724 . . . . 0.02 110.633 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ILE . . . . . . . . . . . . . 20.1 tt -147.64 129.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -86.91 112.92 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.199 -1.037 . . . . 0.02 108.199 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 37.8 mt -78.92 -6.44 56.19 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.411 1.634 . . . . 0.02 115.411 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' ASN . . . . . 0.509 HD21 ' CD1' ' A' ' 55' ' ' ILE . 4.8 m-20 -54.86 -34.44 62.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.215 1.191 . . . . 0.02 114.215 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 95.6 p -89.42 -2.73 58.5 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.662 1.727 . . . . 0.03 115.662 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' B' ' 250' ' ' GLN . 24.3 m -122.65 -9.11 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 114.701 1.371 . . . . 0.02 114.701 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' ILE . . . . . . . . . . . . . 81.2 mt -125.78 141.88 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.899 -0.778 . . . . 0.02 108.899 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLU . . . . . 0.562 ' OE1' ' NE2' ' B' ' 250' ' ' GLN . 11.7 pt-20 -138.28 156.48 47.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.738 0.644 . . . . 0.03 112.738 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -94.09 111.08 22.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.148 -0.933 . . . . 0.02 109.73 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.85 101.62 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.19 -1.041 . . . . 0.03 108.19 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 76' ' ' ARG . 35.4 t0 51.83 44.22 29.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.353 0.871 . . . . 0.03 113.353 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.04 -2.34 81.53 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 117.399 1.719 . . . . 0.02 117.399 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 42.5 t -118.05 130.46 56.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.909 0.355 . . . . 0.02 111.045 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 95.2 mt -75.09 126.55 31.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.498 -0.927 . . . . 0.02 108.498 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -130.18 155.35 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.02 110.012 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' TRP . . . . . . . . . . . . . 59.3 m95 -70.13 152.86 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.277 -1.379 . . . . 0.03 107.277 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' GLN . . . . . 0.94 ' CG ' ' HD2' ' B' ' 251' ' ' PRO . 50.6 tt0 -134.48 159.02 73.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.631 -0.713 . . . . 0.03 111.027 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' PRO . . . . . 0.94 ' HD2' ' CG ' ' B' ' 250' ' ' GLN . 29.8 Cg_endo -53.06 -177.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 N-CA-C 108.971 -1.204 . . . . 0.04 108.971 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 82.9 p -78.73 -179.74 6.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.91 0.707 . . . . 0.03 112.91 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' B' ' 253' ' ' ASN . 2.9 p-10 -74.61 -165.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.466 -0.494 . . . . 0.04 111.52 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.403 ' H ' ' HB2' ' B' ' 253' ' ' ASN . 0.1 OUTLIER -113.51 -33.58 5.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.159 -1.052 . . . . 0.05 108.159 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 255' ' ' ILE . . . . . 0.521 ' CD1' HD21 ' A' ' 37' ' ' ASN . 44.7 pt -71.82 -10.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 120.703 -1.248 . . . . 0.02 112.527 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' GLU . . . . . 0.497 ' HB2' HD21 ' B' ' 253' ' ' ASN . 18.1 tp10 -81.19 -27.86 35.17 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.981 -0.377 . . . . 0.03 109.981 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -116.83 2.81 12.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.659 1.355 . . . . 0.02 114.659 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m -127.18 151.78 48.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.725 -1.213 . . . . 0.02 107.725 178.341 -58.582 -104.102 101.475 105.146 2.038 104.306 -80.467 -65.01 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -136.81 170.86 15.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.49 . . . . 0.02 110.061 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.54 52.82 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.35 0.871 . . . . 0.02 113.35 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 58.6 p -73.34 138.39 45.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.159 -1.423 . . . . 0.02 107.159 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -148.48 154.9 40.47 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.913 -0.315 . . . . 0.01 110.604 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' LEU . . . . . 0.481 ' HB2' HG13 ' A' ' 13' ' ' ILE . 58.3 tp -93.43 113.8 26.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 105.115 -2.18 . . . . 0.02 105.115 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' B' ' 268' ' ' GLU . . . -98.72 119.74 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.027 -1.101 . . . . 0.01 108.027 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.21 -140.04 26.84 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.581 -1.408 . . . . 0.02 109.581 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' SER . . . . . . . . . . . . . 66.4 p -101.99 -12.09 18.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.108 1.521 . . . . 0.02 115.108 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 94.1 p -151.11 5.04 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 117.058 2.244 . . . . 0.02 117.058 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' GLU . . . . . 0.588 ' HB3' ' HB3' ' B' ' 264' ' ' ALA . 18.0 tp10 -93.06 127.7 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.098 1.148 . . . . 0.02 114.098 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 13' ' ' ILE . 24.1 tp -95.65 119.95 35.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.193 -2.151 . . . . 0.02 105.193 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -115.75 148.73 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.249 -0.649 . . . . 0.01 109.249 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -168.28 170.53 9.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.134 0.492 . . . . 0.02 110.854 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.27 116.24 30.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 103.302 -2.851 . . . . 0.02 103.302 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.59 148.31 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.237 1.199 . . . . 0.02 114.237 -178.128 -65.01 -80.467 101.475 104.306 2.038 105.146 -104.102 -58.582 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' LYS . . . . . 0.46 ' HG3' ' CZ ' ' B' ' 280' ' ' PHE . 56.6 mtpt -76.82 138.08 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 0.03 112.663 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' THR . . . . . . . . . . . . . 59.0 p -89.38 178.51 6.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.995 -1.483 . . . . 0.03 106.995 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' ARG . . . . . 0.65 ' HG3' HH11 ' B' ' 276' ' ' ARG . 14.8 mmt85 -61.5 -29.22 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 0.03 108.24 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.17 5.91 13.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.807 -0.633 . . . . 0.03 112.502 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 68.76 26.68 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.263 1.579 . . . . 0.03 115.263 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.85 143.59 44.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.714 -0.847 . . . . 0.03 108.714 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' B' ' 274' ' ' LYS . 52.0 m-85 -84.7 133.66 34.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.258 0.836 . . . . 0.02 113.258 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 281' ' ' VAL . . . . . . . . . . . . . 32.0 m -132.06 158.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.633 -1.247 . . . . 0.02 107.633 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 67.5 m -81.01 138.45 36.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.34 -0.391 . . . . 0.02 111.074 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 9.7 t -150.66 160.02 44.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.274 -0.421 . . . . 0.02 110.639 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.38 160.44 41.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.423 -0.584 . . . . 0.02 109.423 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 20.0 tt -148.01 138.77 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.767 -1.197 . . . . 0.02 107.767 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -83.02 109.35 17.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.759 0.314 . . . . 0.02 111.071 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.99 -20.63 66.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.477 0.547 . . . . 0.02 112.477 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -66.56 -12.37 57.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.811 -0.756 . . . . 0.02 110.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 289' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.01 -41.43 98.06 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.123 0.416 . . . . 0.02 112.123 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -134.8 -4.04 2.53 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 118.098 2.629 . . . . 0.02 118.098 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.24 118.2 46.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 119.7 -0.8 . . . . 0.02 109.019 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 292' ' ' ALA . . . . . . . . . . . . . . . -115.1 160.59 19.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.436 0.902 . . . . 0.02 113.436 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -100.35 102.64 13.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.461 -2.051 . . . . 0.03 105.461 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' ILE . . . . . . . . . . . . . 40.1 mm -100.61 98.31 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.637 -1.246 . . . . 0.03 107.637 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' ASP . . . . . . . . . . . . . 31.9 t0 48.66 46.07 21.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.893 1.072 . . . . 0.03 113.893 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' GLY . . . . . . . . . . . . . . . 94.12 -3.58 70.03 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 117.647 1.819 . . . . 0.03 117.647 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 49.8 m -121.44 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.03 111.701 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.0 127.43 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.02 110.037 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.86 142.61 33.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.941 0.401 . . . . 0.03 111.782 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -82.92 144.36 30.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.738 -0.838 . . . . 0.03 108.738 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 108.786 -0.82 . . . . 0.03 108.786 177.649 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.489 0.185 . . . . 0.03 110.74 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.32 -127.55 23.95 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 117.355 1.702 . . . . 0.02 117.355 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 68.89 22.54 7.12 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 115.942 1.83 . . . . 0.03 115.942 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -54.87 -37.22 65.98 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 114.126 1.158 . . . . 0.02 114.126 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.3 p -55.37 -27.8 49.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.584 1.698 . . . . 0.02 115.584 -176.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -65.97 -25.3 67.04 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 115.332 1.605 . . . . 0.02 115.332 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.3 p -126.77 25.62 6.34 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 114.545 1.313 . . . . 0.03 114.545 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.2 m -134.6 166.85 21.95 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.186 -1.042 . . . . 0.02 108.186 178.849 -53.823 -107.445 98.738 104.696 2.031 103.0 -84.448 -56.619 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -153.02 169.3 23.23 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.153 -0.684 . . . . 0.03 109.153 178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 59.58 38.28 22.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.093 0.473 . . . . 0.02 111.129 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.1 m -76.47 149.05 36.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.944 -0.571 . . . . 0.02 109.773 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.87 152.9 27.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.988 -0.551 . . . . 0.02 111.063 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.648 HD13 HD13 ' B' ' 269' ' ' LEU . 75.9 mt -122.96 130.03 74.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.53 -0.915 . . . . 0.02 108.53 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -133.72 113.47 12.38 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 103.384 -2.821 . . . . 0.02 103.384 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.24 -118.97 12.94 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 107.89 -2.084 . . . . 0.02 107.89 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.5 ' HB3' ' CG2' ' B' ' 255' ' ' ILE . 95.7 p -106.67 3.0 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.572 -0.369 . . . . 0.02 111.42 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.64 127.73 52.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 116.564 2.061 . . . . 0.02 116.564 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.5 tp -100.57 130.84 46.68 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 106.751 -1.574 . . . . 0.02 106.751 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.6 m -125.75 140.43 52.69 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.474 -1.676 . . . . 0.02 106.474 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.1 t -157.25 157.44 34.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.405 -0.518 . . . . 0.02 111.052 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.8 m -106.73 116.15 31.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 105.343 -2.095 . . . . 0.02 105.343 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.1 m -118.69 151.44 37.97 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 117.399 2.37 . . . . 0.03 117.399 -175.352 -56.619 -84.448 98.738 103.0 2.031 104.696 -107.445 -53.823 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.8 136.55 45.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.149 -0.932 . . . . 0.03 112.514 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.28 162.4 14.02 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 106.56 -1.645 . . . . 0.03 106.56 177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.5 m -59.95 -52.44 65.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.831 0.348 . . . . 0.03 111.848 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -72.95 10.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.664 0.616 . . . . 0.04 112.664 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.94 168.74 40.82 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.552 -1.819 . . . . 0.03 108.552 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.22 176.12 49.81 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 109.055 -1.618 . . . . 0.03 109.055 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -133.68 166.46 22.56 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 113.952 1.093 . . . . 0.03 113.952 -178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -146.51 138.68 24.94 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.571 -1.27 . . . . 0.03 107.571 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 95.9 m -102.99 133.8 47.5 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.581 -1.637 . . . . 0.02 106.581 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.0 p -146.54 168.01 22.3 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.02 110.372 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.9 m -132.13 159.72 38.1 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.611 -0.722 . . . . 0.02 110.639 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.65 129.54 6.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.206 -1.035 . . . . 0.02 108.206 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -86.89 112.96 22.28 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.187 -1.042 . . . . 0.02 108.187 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 38.2 mt -79.01 -6.37 56.19 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 115.377 1.621 . . . . 0.02 115.377 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.521 HD21 ' CD1' ' B' ' 255' ' ' ILE . 4.8 m-20 -54.91 -34.42 63.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 114.24 1.2 . . . . 0.02 114.24 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 95.6 p -89.51 -2.63 58.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 115.609 1.707 . . . . 0.02 115.609 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 50' ' ' GLN . 24.5 m -122.62 -9.15 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 114.744 1.387 . . . . 0.02 114.744 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.1 mt -125.72 141.88 44.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.896 -0.779 . . . . 0.02 108.896 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.553 ' OE1' ' NE2' ' A' ' 50' ' ' GLN . 11.7 pt-20 -138.33 156.45 47.62 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.752 0.649 . . . . 0.03 112.752 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -94.1 111.15 22.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.147 -0.933 . . . . 0.02 109.707 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 68.7 t -110.86 101.6 12.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 108.181 -1.044 . . . . 0.03 108.181 178.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' B' ' 276' ' ' ARG . 35.4 t0 51.83 44.18 29.55 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.392 0.886 . . . . 0.03 113.392 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.08 -2.39 81.51 Favored Glycine 0 C--N 1.333 0.361 0 N-CA-C 117.405 1.722 . . . . 0.02 117.405 177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.4 t -118.01 130.55 56.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.881 0.341 . . . . 0.02 111.048 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -75.13 126.48 31.12 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.535 -0.913 . . . . 0.02 108.535 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -130.13 155.45 46.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.064 -0.516 . . . . 0.02 110.025 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CE2' ' HD2' ' B' ' 290' ' ' HIS . 57.6 m95 -69.96 151.95 45.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 107.267 -1.383 . . . . 0.03 107.267 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.936 ' CG ' ' HD2' ' A' ' 51' ' ' PRO . 49.9 tt0 -133.3 158.93 74.5 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.605 -0.725 . . . . 0.03 111.057 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.936 ' HD2' ' CG ' ' A' ' 50' ' ' GLN . 30.1 Cg_endo -53.11 -177.41 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.193 0 N-CA-C 108.972 -1.203 . . . . 0.04 108.972 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 83.6 p -78.96 -179.94 6.93 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.922 0.712 . . . . 0.03 112.922 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 53' ' ' ASN . 2.7 p-10 -73.09 -165.46 0.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.448 -0.501 . . . . 0.04 111.509 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' HE2' ' CB ' ' B' ' 216' ' ' SER . 0.1 OUTLIER -113.18 -32.46 6.3 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.16 -1.052 . . . . 0.04 108.16 -178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.51 ' CG2' ' HB3' ' B' ' 216' ' ' SER . 44.7 pt -74.48 -10.72 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 112.541 0.571 . . . . 0.02 112.541 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.497 ' HB2' HD21 ' A' ' 53' ' ' ASN . 18.1 tp10 -81.15 -27.85 35.31 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 110.015 -0.365 . . . . 0.03 110.015 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.8 p -116.86 2.76 12.85 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 114.627 1.343 . . . . 0.02 114.627 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.6 m -127.14 151.81 48.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.779 -1.193 . . . . 0.02 107.779 178.299 -58.519 -104.154 101.525 105.113 2.038 104.25 -80.485 -64.993 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -136.8 170.89 15.34 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.174 0.511 . . . . 0.02 110.047 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.55 52.8 14.12 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 113.312 0.856 . . . . 0.01 113.312 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 p -73.32 138.31 45.34 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.177 -1.416 . . . . 0.01 107.177 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -148.39 154.96 40.63 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.938 -0.305 . . . . 0.01 110.634 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 58.1 tp -93.49 113.84 26.07 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 105.082 -2.192 . . . . 0.02 105.082 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 68' ' ' GLU . . . -98.77 119.75 38.05 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.018 -1.104 . . . . 0.01 108.018 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.24 -140.05 26.83 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 109.531 -1.428 . . . . 0.02 109.531 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.7 p -102.04 -11.96 18.5 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 115.105 1.52 . . . . 0.02 115.105 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 92.7 p -151.13 5.03 0.47 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 117.072 2.249 . . . . 0.02 117.072 -178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' ' 64' ' ' ALA . 18.0 tp10 -93.03 127.71 38.65 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 114.129 1.159 . . . . 0.01 114.129 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.2 tp -95.65 119.96 35.07 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 105.159 -2.163 . . . . 0.02 105.159 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -115.76 148.75 39.48 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.342 -0.614 . . . . 0.01 109.342 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -168.3 170.5 9.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.159 0.504 . . . . 0.01 110.864 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.26 116.25 30.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 103.343 -2.836 . . . . 0.02 103.343 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 92.7 m -118.51 148.4 42.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 114.229 1.196 . . . . 0.02 114.229 -178.1 -64.993 -80.485 101.525 104.25 2.038 105.113 -104.154 -58.519 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 56.6 mtpt -76.94 138.12 39.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.66 -0.7 . . . . 0.03 112.558 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.1 p -89.43 178.52 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.979 -1.489 . . . . 0.03 106.979 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.643 ' HG3' HH11 ' A' ' 76' ' ' ARG . 14.8 mmt85 -61.5 -29.19 69.83 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.293 -1.002 . . . . 0.03 108.293 178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.18 5.92 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.721 -0.672 . . . . 0.03 112.463 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 68.7 26.63 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 115.327 1.602 . . . . 0.03 115.327 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -114.85 143.64 44.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.702 -0.851 . . . . 0.03 108.702 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.466 ' CZ ' ' HG3' ' A' ' 74' ' ' LYS . 51.9 m-85 -84.64 133.58 34.4 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.242 0.831 . . . . 0.02 113.242 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.2 m -132.02 158.88 43.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.686 -1.227 . . . . 0.02 107.686 178.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.6 t -81.91 137.18 35.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.02 111.108 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.7 t -149.57 159.98 43.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.02 110.62 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.41 160.4 41.63 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.381 -0.6 . . . . 0.02 109.381 178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.0 tt -147.88 138.81 17.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.779 -1.193 . . . . 0.02 107.779 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -83.03 109.27 16.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.815 0.341 . . . . 0.02 111.13 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.98 -20.54 65.97 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.522 0.564 . . . . 0.02 112.522 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -66.6 -12.35 57.53 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 119.811 -0.756 . . . . 0.02 110.896 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -62.04 -41.44 98.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.074 0.398 . . . . 0.02 112.074 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.563 ' HD2' ' CE2' ' B' ' 249' ' ' TRP . 92.3 m-70 -134.81 -4.03 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 118.065 2.617 . . . . 0.02 118.065 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.25 118.19 46.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 119.754 -0.779 . . . . 0.02 109.056 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -115.14 160.62 19.46 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 113.447 0.906 . . . . 0.03 113.447 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -100.41 102.65 13.92 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 105.473 -2.047 . . . . 0.03 105.473 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 40.2 mm -100.63 98.25 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 107.608 -1.256 . . . . 0.03 107.608 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 32.0 t0 48.79 46.01 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.843 1.053 . . . . 0.03 113.843 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.04 -3.49 70.19 Favored Glycine 0 C--N 1.332 0.343 0 N-CA-C 117.672 1.829 . . . . 0.03 117.672 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.1 m -121.43 134.16 55.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.493 0.647 . . . . 0.03 111.742 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.04 127.44 32.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.03 110.039 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.87 142.5 33.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.03 111.8 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -82.82 144.4 30.15 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.825 -0.805 . . . . 0.03 108.825 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--N 1.327 -0.396 0 N-CA-C 108.764 -0.828 . . . . 0.03 108.764 177.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 120.503 0.192 . . . . 0.03 110.69 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . 68.27 -127.53 24.06 Favored Glycine 0 C--N 1.333 0.387 0 N-CA-C 117.346 1.698 . . . . 0.02 117.346 178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' LYS . . . . . . . . . . . . . 90.2 mttt 68.87 22.55 7.15 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 115.951 1.834 . . . . 0.03 115.951 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -54.9 -37.23 66.06 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 114.11 1.152 . . . . 0.02 114.11 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' SER . . . . . . . . . . . . . 60.3 p -55.33 -27.86 49.87 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.598 1.703 . . . . 0.02 115.598 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -65.95 -25.29 67.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 115.382 1.623 . . . . 0.03 115.382 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 65.5 p -126.72 25.65 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 114.539 1.311 . . . . 0.03 114.539 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' CYS . . . . . . . . . . . . . 56.2 m -134.6 166.82 22.01 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.238 -1.023 . . . . 0.02 108.238 178.86 -53.786 -107.447 98.735 104.694 2.03 103.005 -84.535 -56.534 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -153.06 169.28 23.33 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.141 -0.688 . . . . 0.03 109.141 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 59.65 38.23 22.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.001 0.429 . . . . 0.02 111.13 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' SER . . . . . . . . . . . . . 70.0 m -76.48 149.03 36.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.952 -0.567 . . . . 0.02 109.722 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' ALA . . . . . . . . . . . . . . . -156.83 152.96 27.51 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.905 -0.589 . . . . 0.02 110.939 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.52 HD13 ' HA ' ' B' ' 218' ' ' LEU . 16.5 mm -120.43 129.79 75.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.206 -0.906 . . . . 0.02 108.686 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -135.13 113.51 11.46 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 103.374 -2.824 . . . . 0.02 103.374 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.25 -119.0 12.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 107.947 -2.061 . . . . 0.02 107.947 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' SER . . . . . 0.51 ' HB3' ' CG2' ' A' ' 55' ' ' ILE . 95.6 p -106.65 3.07 26.4 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 122.609 -0.348 . . . . 0.02 111.431 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 40.8 t -99.64 127.7 52.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 116.604 2.076 . . . . 0.02 116.604 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.52 ' HA ' HD13 ' B' ' 213' ' ' ILE . 19.4 tp -100.57 130.86 46.69 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.762 -1.57 . . . . 0.02 106.762 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 98.0 m -125.76 140.45 52.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 106.458 -1.682 . . . . 0.02 106.458 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 19.1 t -157.22 157.46 34.36 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.418 -0.513 . . . . 0.02 111.083 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' THR . . . . . . . . . . . . . 96.2 m -106.79 116.24 31.58 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 105.332 -2.099 . . . . 0.03 105.332 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' CYS . . . . . . . . . . . . . 61.9 m -118.71 151.43 38.0 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 117.448 2.388 . . . . 0.03 117.448 -175.358 -56.534 -84.535 98.735 103.005 2.03 104.694 -107.447 -53.786 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.78 136.54 45.48 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 115.225 -0.898 . . . . 0.03 112.484 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.25 162.38 14.03 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.593 -1.632 . . . . 0.04 106.593 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 85.2 m -59.88 -52.52 65.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.766 0.317 . . . . 0.04 111.837 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -73.0 11.03 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.594 0.591 . . . . 0.04 112.594 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' GLY . . . . . . . . . . . . . . . 91.95 168.76 40.83 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -1.833 . . . . 0.04 108.518 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' GLY . . . . . . . . . . . . . . . 86.12 176.12 49.89 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 109.117 -1.593 . . . . 0.04 109.117 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -133.64 166.46 22.55 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 114.016 1.117 . . . . 0.03 114.016 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -146.5 138.69 24.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.537 -1.283 . . . . 0.03 107.537 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' THR . . . . . . . . . . . . . 95.8 m -102.99 133.82 47.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.582 -1.636 . . . . 0.03 106.582 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 95.7 p -146.52 168.04 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.041 0.448 . . . . 0.03 110.385 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 54.3 m -132.2 159.7 38.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.608 -0.724 . . . . 0.02 110.633 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ILE . . . . . . . . . . . . . 20.1 tt -147.64 129.59 6.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.154 -1.054 . . . . 0.02 108.154 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -86.91 112.92 22.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.199 -1.037 . . . . 0.02 108.199 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 37.8 mt -78.92 -6.44 56.19 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 115.411 1.634 . . . . 0.02 115.411 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' ASN . . . . . 0.509 HD21 ' CD1' ' A' ' 55' ' ' ILE . 4.8 m-20 -54.86 -34.44 62.95 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 114.215 1.191 . . . . 0.02 114.215 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' SER . . . . . . . . . . . . . 95.6 p -89.42 -2.73 58.5 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.662 1.727 . . . . 0.03 115.662 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' B' ' 250' ' ' GLN . 24.3 m -122.65 -9.11 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 114.701 1.371 . . . . 0.02 114.701 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' ILE . . . . . . . . . . . . . 81.2 mt -125.78 141.88 44.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.899 -0.778 . . . . 0.02 108.899 178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLU . . . . . 0.562 ' OE1' ' NE2' ' B' ' 250' ' ' GLN . 11.7 pt-20 -138.28 156.48 47.62 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.738 0.644 . . . . 0.03 112.738 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' ASN . . . . . . . . . . . . . 17.7 t30 -94.09 111.08 22.76 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.148 -0.933 . . . . 0.02 109.73 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.85 101.62 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.19 -1.041 . . . . 0.03 108.19 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 76' ' ' ARG . 35.4 t0 51.83 44.22 29.51 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.353 0.871 . . . . 0.03 113.353 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' GLY . . . . . . . . . . . . . . . 90.04 -2.34 81.53 Favored Glycine 0 C--N 1.332 0.338 0 N-CA-C 117.399 1.719 . . . . 0.02 117.399 177.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' SER . . . . . . . . . . . . . 42.5 t -118.05 130.46 56.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.909 0.355 . . . . 0.02 111.045 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' LEU . . . . . . . . . . . . . 95.2 mt -75.09 126.55 31.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.498 -0.927 . . . . 0.02 108.498 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -130.18 155.35 46.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.071 -0.513 . . . . 0.02 110.012 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' TRP . . . . . 0.563 ' CE2' ' HD2' ' A' ' 90' ' ' HIS . 59.3 m95 -70.13 152.86 43.83 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.277 -1.379 . . . . 0.03 107.277 -178.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . 0.94 ' CG ' ' HD2' ' B' ' 251' ' ' PRO . 50.6 tt0 -134.48 159.02 73.83 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.631 -0.713 . . . . 0.03 111.027 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' PRO . . . . . 0.94 ' HD2' ' CG ' ' B' ' 250' ' ' GLN . 29.8 Cg_endo -53.06 -177.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 N-CA-C 108.971 -1.204 . . . . 0.04 108.971 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 82.9 p -78.73 -179.74 6.69 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.91 0.707 . . . . 0.03 112.91 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' B' ' 253' ' ' ASN . 2.9 p-10 -74.61 -165.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.466 -0.494 . . . . 0.04 111.52 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.403 ' H ' ' HB2' ' B' ' 253' ' ' ASN . 0.1 OUTLIER -113.51 -33.58 5.84 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.159 -1.052 . . . . 0.05 108.159 -179.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' ILE . . . . . 0.521 ' CD1' HD21 ' A' ' 37' ' ' ASN . 44.7 pt -71.82 -10.6 14.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 O-C-N 120.703 -1.248 . . . . 0.02 112.527 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' GLU . . . . . 0.497 ' HB2' HD21 ' B' ' 253' ' ' ASN . 18.1 tp10 -81.19 -27.86 35.17 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.981 -0.377 . . . . 0.03 109.981 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -116.83 2.81 12.88 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 114.659 1.355 . . . . 0.02 114.659 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' CYS . . . . . . . . . . . . . 71.6 m -127.18 151.78 48.23 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.725 -1.213 . . . . 0.02 107.725 178.341 -58.582 -104.102 101.475 105.146 2.038 104.306 -80.467 -65.01 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -136.81 170.86 15.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.121 -0.49 . . . . 0.02 110.061 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.54 52.82 14.08 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.35 0.871 . . . . 0.02 113.35 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' THR . . . . . . . . . . . . . 58.6 p -73.34 138.39 45.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.159 -1.423 . . . . 0.02 107.159 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -148.48 154.9 40.47 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.913 -0.315 . . . . 0.01 110.604 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' LEU . . . . . 0.481 ' HB2' HG13 ' A' ' 13' ' ' ILE . 58.3 tp -93.43 113.8 26.04 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 105.115 -2.18 . . . . 0.02 105.115 176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' ALA . . . . . 0.588 ' HB3' ' HB3' ' B' ' 268' ' ' GLU . . . -98.72 119.74 37.98 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.027 -1.101 . . . . 0.01 108.027 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' GLY . . . . . . . . . . . . . . . 74.21 -140.04 26.84 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 109.581 -1.408 . . . . 0.02 109.581 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' SER . . . . . . . . . . . . . 66.4 p -101.99 -12.09 18.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 115.108 1.521 . . . . 0.02 115.108 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' SER . . . . . . . . . . . . . 94.1 p -151.11 5.04 0.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 117.058 2.244 . . . . 0.02 117.058 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' GLU . . . . . 0.588 ' HB3' ' HB3' ' B' ' 264' ' ' ALA . 18.0 tp10 -93.06 127.7 38.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 114.098 1.148 . . . . 0.02 114.098 -178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.648 HD13 HD13 ' A' ' 13' ' ' ILE . 24.1 tp -95.65 119.95 35.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 105.193 -2.151 . . . . 0.02 105.193 176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' ALA . . . . . . . . . . . . . . . -115.75 148.73 39.48 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.249 -0.649 . . . . 0.01 109.249 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' ALA . . . . . . . . . . . . . . . -168.28 170.53 9.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.134 0.492 . . . . 0.02 110.854 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -111.27 116.24 30.69 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 103.302 -2.851 . . . . 0.02 103.302 177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' CYS . . . . . . . . . . . . . 93.0 m -118.59 148.31 42.81 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.237 1.199 . . . . 0.02 114.237 -178.128 -65.01 -80.467 101.475 104.306 2.038 105.146 -104.102 -58.582 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . 0.46 ' HG3' ' CZ ' ' B' ' 280' ' ' PHE . 56.6 mtpt -76.82 138.08 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 0.03 112.663 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' THR . . . . . . . . . . . . . 59.0 p -89.38 178.51 6.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.995 -1.483 . . . . 0.03 106.995 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' ARG . . . . . 0.65 ' HG3' HH11 ' B' ' 276' ' ' ARG . 14.8 mmt85 -61.5 -29.22 69.85 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.24 -1.022 . . . . 0.03 108.24 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' ALA . . . . . . . . . . . . . . . -80.17 5.91 13.16 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.807 -0.633 . . . . 0.03 112.502 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 68.76 26.68 6.02 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 115.263 1.579 . . . . 0.03 115.263 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -114.85 143.59 44.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.714 -0.847 . . . . 0.03 108.714 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . 0.46 ' CZ ' ' HG3' ' B' ' 274' ' ' LYS . 52.0 m-85 -84.7 133.66 34.38 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 113.258 0.836 . . . . 0.02 113.258 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' VAL . . . . . . . . . . . . . 32.0 m -132.06 158.76 43.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.633 -1.247 . . . . 0.02 107.633 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' SER . . . . . . . . . . . . . 67.5 m -81.01 138.45 36.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.34 -0.391 . . . . 0.02 111.074 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' THR . . . . . . . . . . . . . 9.7 t -150.66 160.02 44.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.274 -0.421 . . . . 0.02 110.639 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -154.38 160.44 41.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.423 -0.584 . . . . 0.02 109.423 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 20.0 tt -148.01 138.77 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.767 -1.197 . . . . 0.02 107.767 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -83.02 109.35 17.03 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.759 0.314 . . . . 0.02 111.071 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.99 -20.63 66.04 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.477 0.547 . . . . 0.02 112.477 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -66.56 -12.37 57.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.811 -0.756 . . . . 0.02 110.951 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -62.01 -41.43 98.06 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 112.123 0.416 . . . . 0.02 112.123 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' HIS . . . . . 0.588 ' HD2' ' CE2' ' A' ' 49' ' ' TRP . 92.4 m-70 -134.8 -4.04 2.53 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 118.098 2.629 . . . . 0.02 118.098 -176.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' ILE . . . . . . . . . . . . . 43.1 mm -100.24 118.2 46.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 119.7 -0.8 . . . . 0.02 109.019 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' ALA . . . . . . . . . . . . . . . -115.1 160.59 19.47 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 113.436 0.902 . . . . 0.02 113.436 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -100.35 102.64 13.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.461 -2.051 . . . . 0.03 105.461 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' ILE . . . . . . . . . . . . . 40.1 mm -100.61 98.31 6.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.637 -1.246 . . . . 0.03 107.637 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' ASP . . . . . . . . . . . . . 31.9 t0 48.66 46.07 21.42 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.893 1.072 . . . . 0.03 113.893 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' GLY . . . . . . . . . . . . . . . 94.12 -3.58 70.03 Favored Glycine 0 C--N 1.331 0.29 0 N-CA-C 117.647 1.819 . . . . 0.03 117.647 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' THR . . . . . . . . . . . . . 49.8 m -121.44 134.12 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.03 111.701 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.0 127.43 32.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.215 -0.448 . . . . 0.02 110.037 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -141.86 142.61 33.11 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.941 0.401 . . . . 0.03 111.782 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -82.92 144.36 30.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.738 -0.838 . . . . 0.03 108.738 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--N 1.326 -0.421 0 N-CA-C 108.786 -0.82 . . . . 0.03 108.786 177.649 . . . . . . . . 0 0 . 1 stop_ save_